Interferon-inducer antivirals
Aus coViki
(Unterschied zwischen Versionen)
Ossip Groth (Diskussion | Beiträge)
(Die Seite wurde neu angelegt: „{{up|PHA antivirals by mechanism}} {{qt|Interferons}} {{tp|p=C7705326|t=2021. Interferon-inducer antivirals: Potential candidates to combat COVID-19.|pdf=|usr…“)
(Die Seite wurde neu angelegt: „{{up|PHA antivirals by mechanism}} {{qt|Interferons}} {{tp|p=C7705326|t=2021. Interferon-inducer antivirals: Potential candidates to combat COVID-19.|pdf=|usr…“)
Aktuelle Version vom 11. April 2021, 16:57 Uhr
| PHA antivirals by mechanism |
| Interferons |
C7705326 2021. Interferon-inducer antivirals: Potential candidates to combat COVID-19.
33289002 2020. Enhancement of the IFN-beta-induced host signature informs repurposed drugs for COVID-19.
32061635 2020. Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus.
32616594 2020. Cyclophilin Inhibitors Restrict Middle East Respiratory Syndrome Coronavirus Via Interferon lambda In Vitro And In Mice.
32672049 2020. Reply to Jakovac: COVID-19, vitamin D, and type I interferon.
33252301 2020. Nanomedicinal delivery of stimulator of interferon genes agonists: recent advances in virus vaccination.
